Trump tariff shock spreads to U.S. IPO market as several companies' plans to go public change

Golden Finance reports that a glimmer of hope for an imminent recovery in U.S. IPOs has vanished, according to the Wall Street Journal. Ticketing marketplace StubHub and fintech firm Klarna have postponed their IPO roadshows, which were scheduled to begin next week, according to people familiar with the matter. Chime, another fintech company that is delaying the filing of public financial reports with regulators, has also postponed its IPO, some of those people said. virtual physical therapy company Hinge Health is eyeing the market and expects to go public by the end of April, people familiar with the matter said. Cryptocurrency company Circle is close to the next step of going public, but is now anxiously watching before deciding what to do. In addition, there are reports that Medline, a medical technology company, is delaying its U.S. IPO. the stock market crash on Thursday and Friday closed the door on companies waiting to go public. The U.S. IPO market has gone through a rough patch over the past three years, but many bankers and lawyers were hopeful that 2025 would be the year IPOs returned to their normal pace. Instead, a global trade war is roiling the stock market, rattling investors and executives alike.